Cited by 253Advanced Glycation End Products researchReceptor Mechanisms and SignalingProtein Structure and Dynamics

Structural Basis for Pattern Recognition by the Receptor for Advanced Glycation End Products (RAGE)

Open access
Xie, Jingjing, Reverdatto, Sergey, Frolov, Andrej, Hoffmann, Ralf, Burz, David S., Shekhtman, Alexander·2008·Journal of Biological Chemistry

Abstract

The receptor for advanced glycated end products (RAGE) is a multiligand receptor that is implicated in the pathogenesis of various diseases, including diabetic complications, neurodegenerative disorders, and inflammatory responses. The ability of RAGE to recognize advanced glycated end products (AGEs) formed by nonenzymatic glycoxidation of cellular proteins places RAGE in the category of pattern recognition receptors. The structural mechanism of AGE recognition was an enigma due to the diversity of chemical structures found in AGE-modified proteins. Here, using NMR spectroscopy we showed that the immunoglobulin V-type domain of RAGE is responsible for recognizing various classes of AGEs. Three distinct surfaces of the V domain were identified to mediate AGE-V domain interactions. They are located in the positively charged areas of the V domain. The first interaction surface consists of strand C and loop CC ', the second interaction surface consists of strand C ', strand F, and loop FG, and the third interaction surface consists of strand A ' and loop EF. The secondary structure elements of the interaction surfaces exhibit significant flexibility on the ms-micros time scale. Despite highly specific AGE-V domain interactions, the binding affinity of AGEs for an isolated V domain is low, approximately 10 microm. Using in-cell fluorescence resonance energy transfer we show that RAGE is a constitutive oligomer on the plasma membrane. We propose that constitutive oligomerization of RAGE is responsible for recognizing patterns of AGE-modified proteins with affinities less than 100 nm.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m801622200

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Circulating advanced glycation end product levels could not be identified as an independent risk factor for cardiovascular or renal outcomes in diabetic subjects with diabetic nephropathy.

    “In contrast to the aforementioned reports, circulating AGE levels could not be identified as an independent risk factor for cardiovascular or renal outcomes in diabetic subjects with diabetic nephropathy (524) , and circulating AGE levels were even inversely correlated with mortality in haemodialysis patients, the latter most probably due to a better nutritional status (525) .”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Walters, K. J., Gassner, G. T., Lippard, S. J., and Wagner, G. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 7877-7882
  2. Jencks, W. P. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 4046 -4050

Cited by

Sorted by citations

Authors
Xie, J., Reverdatto, S., Frolov, A., Hoffmann, R., Burz, D. S., & Shekhtman, A.
Affiliations
  • State University of New York (US)
  • Leipzig University (DE)
Corresponding author
Shekhtman, Alexander
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2008-10
Volume
283
Issue
40
Pages
27255-27269
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2038792388
Cited by
252
References
81
Citations by year
2026: 6 · 2025: 12 · 2024: 11 · 2023: 15 · 2022: 16 · 2021: 13 · 2020: 14 · 2019: 15 · 2018: 10 · 2017: 8 · 2016: 15 · 2015: 13 · 2014: 13 · 2013: 22 · 2012: 17
FWCI
11.52
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
American Diabetes Association
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
Keywords
receptor for advanced glycation end products, RAGE, advanced glycation end products, pattern recognition receptors, protein-protein interaction surfaces, plasma membrane, binding affinity, diabetes complications, neurodegenerative diseases, inflammation
MeSH terms
Receptor for Advanced Glycation End Products, Cell Line, Humans, Inflammation, Magnetic Resonance Spectroscopy, Protein Binding, Structure-Activity Relationship, Glycation End Products, Advanced, Protein Structure, Secondary, Protein Structure, Tertiary, Neurodegenerative Diseases, Protein Structure, Quaternary, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review